Clinical Trials

Showing trials with last updates posted in 2026.

NCT06092814 | RECRUITING | NA
120 participants

tACS to Enhance Language Abilities

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-24
Start Date:
2024-07-12
Completion:
2028-08-31
Conditions
  • Stroke
  • Aphasia, Acquired
  • Aphasia
Interventions
  • DEVICE
No Results Yet
NCT06084481 | RECRUITING | PHASE1
325 participants

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-24
Start Date:
2023-11-09
Completion:
2027-09-30
Conditions
  • Hepatocellular Carcinoma
  • Pancreatic Ductal Adenocarcinoma
  • Biliary Tract Cancers
  • Esophageal Squamous Cell Carcinoma
  • Triple Negative Breast Cancer
  • Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
  • Head and Neck Squamous-Cell Carcinoma
  • Platinum Resistant High Grade Epithelial Ovarian Cancer
Interventions
  • DRUG
No Results Yet
NCT05966415 | ACTIVE_NOT_RECRUITING | PHASE2
64 participants

Endocalyx for Heart Failure

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-24
Start Date:
2023-04-21
Completion:
2026-09-01
Conditions
  • Chronic Heart Failure
Interventions
  • DIETARY_SUPPLEMENT
  • OTHER
No Results Yet
NCT05765812 | RECRUITING | PHASE1/PHASE2
116 participants

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-24
Start Date:
2023-05-15
Completion:
2028-09-30
Conditions
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
  • Astrocytoma, Grade III
Interventions
  • DRUG
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page